ZIOPHARM ONCOLOGY INC 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jan 4, 2017
Insider Transaction Report
Form 4
Cooper Laurence James Neil
Chief Executive Officer
Transactions
- Tax Payment
Common Stock
2016-12-31$5.35/sh−17,292$92,512→ 1,209,291 total - Award
Common Stock
2016-12-30+212,250→ 1,226,583 total
Footnotes (2)
- [F1]70,750 shares vest on each of 12/30/2017, 12/30/2018 and 12/30/2019.
- [F2]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.